About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNCT00718003

Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).

The literature to date indicates that noninvasive positive pressure ventilation (NIPPV) provides effective noninvasive ventilator support, prolongs survival, and improves quality of life (QOL) in Amyo...

Lead sponsor: Drexel University College of Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Drexel University College of Medicine

Collaborators

MDA/ALS Center of Hope

Age

20 - 85 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with probable or definite ALS by El Escorial Criteria between ages 20-85 will be included for evaluation. They must have progression of disease over the preceding 6 months and duration of disease less then 5 years.

Exclusion Criteria

•Patients who do not meet clinical criteria of the diagnosis including those with pure upper motor neuron syndromes (PLS) or pure lower motor syndromes (SMA, Multifocal conduction block, motor neuropathies).

Related studies

Ultra-high-caloric, Fatty Diet in ALS

NCT06280079 · Amyotrophic Lateral Sclerosis

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

NCT06051123 · ALSFTD, ALS (Amyotrophic Lateral Sclerosis), and more

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

NCT07545473 · Dementia, Neurodegenerative Diseases, and more

RECRUITINGPhase 3

A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

NCT05204017 · Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2013Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment10

Start dateMay 2005

Last updatedMar 5, 2013

Condition

Amyotrophic Lateral Sclerosis Neurodegenerative Disease Motor Neuron Disease

Locations shown

MDA/ALS Center of Hope

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions